FDA News Releases Apr 30, 2026 FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
FDA News Releases Apr 30, 2026 FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List
FDA News Releases Apr 29, 2026 FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.